Cero Therapeutics Holdings Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,748 | -2,300 | -7,290 | -6,024 | -4,531 |
| Depreciation Amortization | 580 | 286 | 1,117 | 832 | 551 |
| Accounts payable and accrued liabilities | -551 | -287 | 1,281 | 893 | 687 |
| Other Working Capital | -329 | -905 | 540 | 670 | 628 |
| Other Operating Activity | -3,569 | -1,875 | -1,438 | -1,200 | -846 |
| Operating Cash Flow | $-8,617 | $-5,080 | $-5,790 | $-4,829 | $-3,511 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 408 | 408 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 605 | 605 | 605 |
| Debt Repayment | -20 | -20 | -41 | -41 | -41 |
| Common Stock Issued | N/A | N/A | 8 | 8 | 8 |
| Other Financing Activity | 9,361 | 6,769 | 0 | 0 | 0 |
| Financing Cash Flow | $9,749 | $7,158 | $572 | $572 | $572 |
| Beginning Cash Position | 3,479 | 3,479 | 6,820 | 6,820 | 6,820 |
| End Cash Position | 4,611 | 5,557 | 1,601 | 2,562 | 3,880 |
| Net Cash Flow | $1,132 | $2,078 | $-5,218 | $-4,258 | $-2,939 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,617 | -5,080 | -5,790 | -4,829 | -3,511 |
| Free Cash Flow | -8,617 | -5,080 | -5,790 | -4,829 | -3,511 |